LeMaitre Vascular Inc. (NASDAQ:LMAT)’s share price hit a new 52-week high during mid-day trading on Tuesday . The company traded as high as $19.87 and last traded at $19.78, with a volume of 142,323 shares changing hands. The stock had previously closed at $18.35.

A number of equities analysts have issued reports on LMAT shares. Zacks Investment Research lowered LeMaitre Vascular from a “buy” rating to a “hold” rating in a research report on Wednesday, July 6th. Barrington Research upped their target price on LeMaitre Vascular from $18.50 to $20.00 and gave the company an “outperform” rating in a research report on Thursday, July 28th. Brean Capital upped their target price on LeMaitre Vascular from $17.50 to $20.00 and gave the company a “buy” rating in a research report on Thursday, July 28th. Finally, Canaccord Genuity set a $19.00 target price on LeMaitre Vascular and gave the company a “buy” rating in a research report on Thursday, July 28th. Seven equities research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company’s stock. The company presently has an average rating of “Buy” and a consensus target price of $18.94.

The firm’s 50 day moving average price is $16.73 and its 200 day moving average price is $15.31. The stock has a market capitalization of $379.25 million and a price-to-earnings ratio of 41.24.

LeMaitre Vascular (NASDAQ:LMAT) last issued its earnings results on Wednesday, July 27th. The company reported $0.14 earnings per share for the quarter, topping the consensus estimate of $0.11 by $0.03. The firm earned $22.40 million during the quarter, compared to analyst estimates of $21.59 million. The firm’s quarterly revenue was up 12.6% on a year-over-year basis. Analysts predict that LeMaitre Vascular Inc. will post $0.55 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 6th. Stockholders of record on Monday, August 22nd will be issued a dividend of $0.045 per share. This represents a $0.18 dividend on an annualized basis and a dividend yield of 0.98%. The ex-dividend date is Thursday, August 18th.

In other news, CEO George W. Lemaitre sold 19,189 shares of the stock in a transaction dated Wednesday, June 8th. The stock was sold at an average price of $15.01, for a total transaction of $288,026.89. Following the transaction, the chief executive officer now owns 3,521,849 shares of the company’s stock, valued at approximately $52,862,953.49. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Chairman George W. Lemaitre sold 60,037 shares of the stock in a transaction dated Friday, September 2nd. The shares were sold at an average price of $18.30, for a total value of $1,098,677.10. Following the transaction, the chairman now directly owns 3,443,098 shares in the company, valued at approximately $63,008,693.40. The disclosure for this sale can be found here.

LeMaitre Vascular, Inc is a provider of medical devices for the treatment of peripheral vascular disease. The Company and its subsidiaries develop, manufacture and market medical devices and implants used primarily in the field of vascular surgery. It operates in the design, marketing, sales and technical support of medical devices and implants for the treatment of peripheral vascular disease industry segment.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.